Cargando…
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
FoxO transcription factors play a conserved role in longevity and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136551/ https://www.ncbi.nlm.nih.gov/pubmed/21423206 http://dx.doi.org/10.1038/onc.2011.35 |
_version_ | 1782208225937981440 |
---|---|
author | Renault, Valérie M. Thekkat, Pramod U. Hoang, Kimmi L. White, Jamie L. Brady, Colleen A. Broz, Daniela Kenzelmann Venturelli, Ophelia S. Johnson, Thomas M. Oskoui, Philip R. Xuan, Zhenyu Santo, Evan E. Zhang, Michael Q. Vogel, Hannes Attardi, Laura D. Brunet, Anne |
author_facet | Renault, Valérie M. Thekkat, Pramod U. Hoang, Kimmi L. White, Jamie L. Brady, Colleen A. Broz, Daniela Kenzelmann Venturelli, Ophelia S. Johnson, Thomas M. Oskoui, Philip R. Xuan, Zhenyu Santo, Evan E. Zhang, Michael Q. Vogel, Hannes Attardi, Laura D. Brunet, Anne |
author_sort | Renault, Valérie M. |
collection | PubMed |
description | FoxO transcription factors play a conserved role in longevity and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the functional interaction between FoxO and p53 have not been fully explored. Here, we show that p53 transactivates the expression of FoxO3, one of the four mammalian FoxO genes, in response to DNA damaging agents in both mouse embryonic fibroblasts and in thymocytes. We show that p53 transactivates FoxO3 in cells by binding to a site in the second intron of the FoxO3 gene, a genomic region recently found to be associated with extreme longevity in humans. While FoxO3 is not necessary for p53-dependent cell cycle arrest, FoxO3 appears to modulate p53-dependent apoptosis. We also find that FoxO3 loss does not interact with p53 loss for tumor development in vivo, although the tumor spectrum of p53 deficient mice may be affected by FoxO3 loss. Our findings indicate that FoxO3 is a p53 target gene, and suggest that FoxO3 and p53 are part of a regulatory transcriptional network that may play an important role during aging and cancer. |
format | Online Article Text |
id | pubmed-3136551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-31365512012-01-21 The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor Renault, Valérie M. Thekkat, Pramod U. Hoang, Kimmi L. White, Jamie L. Brady, Colleen A. Broz, Daniela Kenzelmann Venturelli, Ophelia S. Johnson, Thomas M. Oskoui, Philip R. Xuan, Zhenyu Santo, Evan E. Zhang, Michael Q. Vogel, Hannes Attardi, Laura D. Brunet, Anne Oncogene Article FoxO transcription factors play a conserved role in longevity and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the functional interaction between FoxO and p53 have not been fully explored. Here, we show that p53 transactivates the expression of FoxO3, one of the four mammalian FoxO genes, in response to DNA damaging agents in both mouse embryonic fibroblasts and in thymocytes. We show that p53 transactivates FoxO3 in cells by binding to a site in the second intron of the FoxO3 gene, a genomic region recently found to be associated with extreme longevity in humans. While FoxO3 is not necessary for p53-dependent cell cycle arrest, FoxO3 appears to modulate p53-dependent apoptosis. We also find that FoxO3 loss does not interact with p53 loss for tumor development in vivo, although the tumor spectrum of p53 deficient mice may be affected by FoxO3 loss. Our findings indicate that FoxO3 is a p53 target gene, and suggest that FoxO3 and p53 are part of a regulatory transcriptional network that may play an important role during aging and cancer. 2011-03-21 2011-07-21 /pmc/articles/PMC3136551/ /pubmed/21423206 http://dx.doi.org/10.1038/onc.2011.35 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Renault, Valérie M. Thekkat, Pramod U. Hoang, Kimmi L. White, Jamie L. Brady, Colleen A. Broz, Daniela Kenzelmann Venturelli, Ophelia S. Johnson, Thomas M. Oskoui, Philip R. Xuan, Zhenyu Santo, Evan E. Zhang, Michael Q. Vogel, Hannes Attardi, Laura D. Brunet, Anne The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor |
title | The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor |
title_full | The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor |
title_fullStr | The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor |
title_full_unstemmed | The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor |
title_short | The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor |
title_sort | pro-longevity gene foxo3 is a direct target of the p53 tumor suppressor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136551/ https://www.ncbi.nlm.nih.gov/pubmed/21423206 http://dx.doi.org/10.1038/onc.2011.35 |
work_keys_str_mv | AT renaultvaleriem theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT thekkatpramodu theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT hoangkimmil theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT whitejamiel theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT bradycolleena theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT brozdanielakenzelmann theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT venturelliophelias theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT johnsonthomasm theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT oskouiphilipr theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT xuanzhenyu theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT santoevane theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT zhangmichaelq theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT vogelhannes theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT attardilaurad theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT brunetanne theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT renaultvaleriem prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT thekkatpramodu prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT hoangkimmil prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT whitejamiel prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT bradycolleena prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT brozdanielakenzelmann prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT venturelliophelias prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT johnsonthomasm prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT oskouiphilipr prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT xuanzhenyu prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT santoevane prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT zhangmichaelq prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT vogelhannes prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT attardilaurad prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor AT brunetanne prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor |